Adenovirus-mediated gene transfer of interferon α improves dimethylnitrosamine-induced liver cirrhosis in rat model

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Gene Therapy

• Publication date

  2003-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.gt.3301949PMID 12704415
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Histological outcome in interferon alpha-2b treated patients with chronic posttransfusion non-A, non-B hepatitis.

  2008cited by this paper
• A Randomized Double-blind Placebo-controlled Trial

  2004cited by this paper
• Pharmacokinetics of recombinant interferon alpha-C

  2004cited by this paper
• Cirrhotic rat livers with extensive fibrosis can be safely transduced with clinical-grade adenoviral vectors. Evidence of cirrhosis reversion

  2002cited by this paper
• Prevention of hepatic cirrhosis in rats by hydroxyl radical scavengers.

  2001cited by this paper
• Expression of matrix metalloproteinases in spontaneous regression of liver fibrosis.

  2001cited by this paper
• Polyethylenimine-mediated gene transfer into pancreatic tumor dissemination in the murine peritoneal cavity

  2001cited by this paper
• Restricted expression of an adenoviral vector encoding Fas ligand (CD95L) enhances safety for cancer gene therapy.

  2000cited by this paper
• Liver cirrhosis is reverted by urokinase-type plasminogen activator gene therapy.

  2000cited by this paper
• Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery.

  2000cited by this paper
• Gene expression of interstitial collagenase in both progressive and recovery phase of rat liver fibrosis induced by carbon tetrachloride.

  2000cited by this paper
• Assessment of efficiency and safety of adenovirus mediated gene transfer into normal and damaged murine livers

  2000cited by this paper
• Changes of liver fibrosis in chronic hepatitis C patients with no response to interferon-α therapy: including quantitative assessment by a morphometric method

  2000cited by this paper
• Hepatocyte growth factor gene therapy of liver cirrhosis in rats

  1999cited by this paper
• Interferon gene transfer by a hepatitis B virus vector efficiently suppresses wild-type virus infection.

  1999cited by this paper
• Reversing liver cirrhosis: impact of gene therapy for liver cirrhosis

  1999cited by this paper
• Interferon therapy lowers the rate of progression to hepatocellular carcinoma in chronic hepatitis C but not significantly in an advanced stage: a retrospective study in 1148 patients. Viral Hepatitis Therapy Study Group.

  1999cited by this paper
• Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat.

  1999cited by this paper
• Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon

  1999cited by this paper
• Adenovirus-mediated gene expression in the septal cells of cirrhotic rat livers.

  1999cited by this paper
• In Vitro Migratory potential of rat quiescent hepatic stellate cells and its augmentation by cell activation

  1999cited by this paper
• Human gene therapy.

  1998cited by this paper
• A triploblast origin for Myxozoa?

  1998cited by this paper
• Regulation of human mesangial cell collagen expression by transforming growth factor-β1.

  1998cited by this paper
• Regression of Hepatic Fibrosis in Hepatitis C with Long-Term Interferon Treatment

  1998cited by this paper
• Effects of long-term administration of interferon alpha in two models of liver fibrosis in rats.

  1998cited by this paper
• Drug delivery and targeting.

  1998cited by this paper
• Liver-Directed Gene Transfer Vectors

  1998cited by this paper
• Effects of long-term administration of interferon α in two models of liver fibrosis in rats

  1998cited by this paper
• Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor.

  1997cited by this paper
• Isolated-organ perfusion for local gene delivery: efficient adenovirus-mediated gene transfer into the liver

  1997cited by this paper
• The treatment of chronic viral hepatitis.

  1997cited by this paper
• Adenoviral Vector-Mediated Gene Expression in the Nervous System of Immunocompetent Wistar and T Cell-Deficient nude Rats: Preferential Survival of Transduced Astroglial Cells in nude Rats

  1997cited by this paper
• Therapy of hepatitis C: Other options

  1997cited by this paper
• Therapy of hepatitis C: Patients with cirrhosis

  1997cited by this paper
• In Vivo Expression of Full-Length Human Dystrophin from Adenoviral Vectors Deleted of All Viral Genes

  1996cited by this paper
• Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome.

  1996cited by this paper
• Tissue inhibitor of metalloproteinase‐1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis

  1996cited by this paper
• [Human gene therapy].

  1996cited by this paper
• Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo

  1996cited by this paper
• Meta‐analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration

  1996cited by this paper
• Treatment of chronic viral hepatitis.

  1994cited by this paper
• The epidemiology of viral hepatitis in the United States.

  1994cited by this paper
• Randomised trial of lymphoblastoid alpha-interferon in chronic hepatitis C. Effects on inflammation, fibrogenesis and viremia.

  1993cited by this paper
• Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies.

  1993cited by this paper
• Transfer of a foreign gene into the brain using adenovirus vectors

  1993cited by this paper
• Book Review Ethical Problems in Dialysis and Transplantation (Developments in Nephrology. Vol. 33.) Edited by Carl M. Kjellstrand and John B. Dossetor. 235 pp., illustrated. Boston, Kluwer Academic, 1992. $108.50. 0-7923-1625-8

  1993cited by this paper
• The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment Strategies

  1993cited by this paper
• Efficient selection for high-expression transfectants with a novel eukaryotic vector.

  1991cited by this paper
• Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy.

  1991cited by this paper
• Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-beta 1 in human fibroblasts. Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression.

  1991cited by this paper
• Efficient selection for high-expression transfectants with a novel eukaryotic vector

  1991cited by this paper
• Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial.

  1989cited by this paper
• A morphological study of the early stages of hepatic fibrosis induced by low doses of dimethylnitrosamine in the rat.

  1987cited by this paper
• A dimethylnitrosamine-induced model of cirrhosis and portal hypertension in the rat.

  1985cited by this paper
• A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections.

  1985cited by this paper
• The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid.

  1961cited by this paper

• More than Toxins-Current Prospects in Designing the Next Generation of Antibody Drug Conjugates.

  2022cites this paper
• Canine interferon lambda 3 expressed using an adenoviral vector effectively induces antiviral activity against canine influenza virus.

  2021cites this paper
• Antibody-Based Targeting of Interferon-Beta-1a Mutein in HER2-Positive Cancer Enhances Antitumor Effects Through Immune Responses and Direct Cell Killing

  2021cites this paper
• Pro- and Anti-fibrogenic Functions of Gram-Negative Bacterial Lipopolysaccharide in the Liver

  2020cites this paper
• Novel antibody-based drugs for PD-L1 and TRAIL-R targeted cancer immunotherapy

  2017cites this paper
• Antibody-Based Cancer Therapy: Successful Agents and Novel Approaches.

  2017cites this paper
• Converting Lymphoma Cells into Potent Antigen-Presenting Cells for Interferon-Induced Tumor Regression

  2017cites this paper
• Effect of Antiviral Therapy on Serum Activity of Angiotensin Converting Enzyme in Patients with Chronic Hepatitis C

  2016cites this paper
• Oncolytic adenovirus expressing interferon alpha in a syngeneic Syrian hamster model for the treatment of pancreatic cancer.

  2015cites this paper
• Antibody-cytokine fusion proteins for treatment of cancer: engineering cytokines for improved efficacy and safety.

  2014cites this paper
• Pathogenesis and reversal of liver fibrosis: Effects of genes and environment

  2013cites this paper
• Targeted delivery of interferon‐α to hepatitis B virus‐infected cells using T‐cell receptor‐like antibodies

  2012cites this paper
• Understanding the Mechanism of Hepatic Fibrosis and Potential Therapeutic Approaches

  2012cites this paper
• Gene therapy in interventional pulmonology: Interferon gene delivery with focus on thoracic malignancies

  2012cites this paper
• AAV vectors transduce hepatocytes in vivo as efficiently in cirrhotic as in healthy rat livers

  2011cites this paper
• Cocktail therapy with a combination of interferon, ribavirin and angiotensin-II type 1 receptor blocker attenuates murine liver fibrosis development.

  2011cites this paper
• Targeted delivery of interferon-alpha via fusion to anti-CD20 results in potent antitumor activity against B-cell lymphoma.

  2010cites this paper
• Inhibitory effect of human interferon‐beta‐1a on activated rat and human hepatic stellate cells

  2010cites this paper
• Administration route‐dependent induction of antitumor immunity by interferon‐alpha gene transfer

  2010cites this paper
• Intratumoral interferon-α gene transfer enhances tumor immunity after allogeneic hematopoietic stem cell transplantation

  2009cites this paper
• PDGF-receptor beta-targeted adenovirus redirects gene transfer from hepatocytes to activated stellate cells.

  2008cites this paper
• Baculovirus-mediated interferon alleviates dimethylnitrosamine-induced liver cirrhosis symptoms in a murine model

  2008cites this paper
• Dual Therapeutic Effects of Interferon-α Gene Therapy in a Rat Hepatocellular Carcinoma Model With Liver Cirrhosis.

  2008cites this paper
• Extracellular matrix interacts with interferon alpha protein: retention and display of cytotoxicity.

  2008cites this paper
• Delivery of viral vectors to hepatic stellate cells in fibrotic livers using HVJ envelopes fused with targeted liposomes

  2007influential citation
• Local interferon‐α gene therapy elicits systemic immunity in a syngeneic pancreatic cancer model in hamster

  2007cites this paper
• Blockade of renin–angiotensin system in antifibrotic therapy

  2007cites this paper
• Targeted and regulable expression of transgenes in hepatic stellate cells and myofibroblasts in culture and in vivo using an adenoviral Cre/loxP system to antagonise hepatic fibrosis

  2006cites this paper
• Mechanisms of liver fibrosis.

  2006cites this paper
• Addressing liver fibrosis with lipid-based drug carriers targeted to hepatic stellate cells

  2006cites this paper
• Adeno-associated virus mediated interferon-gamma inhibits the progression of hepatic fibrosis in vitro and in vivo.

  2005cites this paper
• Combined effect of an ACE inhibitor, perindopril, and interferon on liver fibrosis markers in patients with chronic hepatitis C

  2005cites this paper
• Adenovirus-mediated interferon α gene transfer induces regional direct cytotoxicity and possible systemic immunity against pancreatic cancer

  2005cites this paper
• Intraperitoneal injection of adenovirus expressing antisense K-ras RNA suppresses peritoneal dissemination of hamster syngeneic pancreatic cancer without systemic toxicity.

  2005cites this paper
• Vectores virales en terapia génica. Ventajas de los vectores adenoasociados

  2005cites this paper
• Interferons and Alphavirus Pathogenesis: Implications for Developing Medical Countermeasures

  2005cites this paper
• Future Treatments: Antifibrotic Agents, Nitric Oxide Donors, and Gene Therapy in the Treatment of Portal Hypertension

  2005cites this paper
• Combination of interferon‐β and angiotensin‐converting enzyme inhibitor, perindopril, attenuates the murine liver fibrosis development

  2005cites this paper
• Interferon-alpha gene therapy prevents aflatoxin and carbon tetrachloride promoted hepatic carcinogenesis in rats.

  2005cites this paper
• Development of gene therapy to target pancreatic cancer

  2004cites this paper
• Apoptotic cell death as a target for the treatment of acute and chronic liver injury

  2004cites this paper
• Interferon-alpha and antisense K-ras RNA combination gene therapy against pancreatic cancer.

  2004cites this paper
• Interferon‐α and antisense K‐ras RNA combination gene therapy against pancreatic cancer

  2004cites this paper
• Smad4 antisense gene transfer into ito cells and suppressed extracellular matrix production

  2003cites this paper
• Adenovirus-mediated gene transfer of interferon alpha inhibits hepatitis C virus replication in hepatocytes.

  2003cites this paper
• liver fibrosis with lipid-based drug carriers targeted to hepatic stellate cells

  year unknowncites this paper
• Dual Therapeutic Effects of Interferon-α Gene Therapy in a Rat Hepatocellular Carcinoma Model With Liver Cirrhosis

  year unknowncites this paper